Marc Elia
M28 Capital Management Lp
Assets Managed
$53.799M
Holdings
9
Last Quarter
2026 - Q1
Filed Date
1mo 1d ago
Growth Rate
-60.89%(2Q avg: 20.7%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in M28 Capital Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 9 positions.
Assets under management
The assets under management (AUM) of M28 Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 53.799M in assets, with a quarterly growth rate of -60.89% and a 2-quarter average growth rate of 20.7%. The portfolio is managed by Marc Elia, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
WVE Wave Life Sciences Ltd
| 61.84% | $33.265M 4.588M shares@ $7.25 avg price | Decreased -18.99% |
IVVD Invivyd Inc
| 22.35% | $12.023M 9.248M shares@ $1.3 avg price | |
TGTX Tg Therapeutics Inc
| 5.46% | $2.935M 88,354 shares@ $33.23 avg price | Decreased -45.32% |
ARWR Arrowhead Pharmaceuticals In
| 4.3% | $2.311M 36,851 shares@ $62.71 avg price | Decreased -45.32% |
PRQR Proqr Therapeutics Nv
| 1.81% | $971,665 599,793 shares@ $1.63 avg price | Decreased -41.16% |
GUTS Fractyl Health Inc
| 1.58% | $849,730 1.856M shares@ $0.46 avg price | |
RCKT Rocket Pharmaceuticals Inc
| 1.41% | $754,918 210,871 shares@ $3.58 avg price | Decreased -45.32% |
SLN Silence Therapeutics Plc-adr
| 1% | $533,340 101,203 shares@ $5.28 avg price | Decreased -45.32% |
CRIS Curis Inc
| 0.29% | $155,920 284,889 shares@ $0.55 avg price | Decreased -45.32% |
1-9 of 9